New healthcare firm ‘has potential’

Share price has gone up by 22% since the start of 2017, but there was a drop of 1.5% last week, breaking two consecutive weeks of gains

Undergoing short surgical and diagnostic procedures at these facilities cuts both costs and the risk of cross-infection, but occupancy levels are at just ...

CEO Stephen Saad says the company is ‘in a great space’ to make further acquisitions ‘because we have our teams in the right place and ...

The $71m deal will strengthen the Private hospital group’s presence in the Swiss market

However, GTC has found that the larger schemes are attracting the bulk of new members mainly because of their reputations

The market is keeping a close eye on the global move to review pharmaceutical practices, says analyst

The Italian case relates to the prices of a portfolio of off-patent cancer drugs Aspen acquired from GlaxoSmithKline years ago

JP Morgan report by analysts says the longer-term structural outlook and ultimate earnings recovery are good

The African manufacturer is being investigated in Europe, as Roche and Pfizer also come under scrutiny in SA

Private hospital group says André Meyer will step down by the end June to pursue other interests

The long-term insurance ombudsman overrides a clause about waiting periods, forcing the insurer to pay for eight days of hospitalisation

The final price for Cyprus’s NHP Natural Health Pharma depends on its performance over the next three years

CEO Danie Meintjes explains Mediclinic’s strained Middle East strategy to Giulietta Talevi

Four South African clinics have been recognised by the Council for Health Service Accreditation of Southern Africa

The DA had asked the Competition Commission and the Medicines Control Council to investigate Aspen’s market conduct